Marshall Wace’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Marshall Wace’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-620,603	Closed	-$6.38M	–	3401
2022 Q4	$6.38M	Hold	620,603	–	–	0.01%	1038
2022 Q3	$6.25M	Buy	620,603 +92,955	+18%	+$933K	0.01%	1206
2022 Q2	$5.29M	Buy	527,648 +2,250	+0.4%	+$22.5K	0.01%	1296
2022 Q1	$5.25M	Buy	525,398 +414,373	+373%	+$4.12M	0.01%	1323
2021 Q4	$1.1M	Buy	+111,025	New	+$1.1M	﹤0.01%	2431

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Marshall Wace's IQMD Position: Q1 2023 in Review

Marshall Wace sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 620,603 shares — an estimated $6.38M sold.

Marshall Wace first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $6.38M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Marshall Wace reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Marshall Wace sold 620,603 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $6.38M.
Marshall Wace first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Marshall Wace's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $6.38M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.